Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Exon 51 specific phosphorothioate oligonucleotide

EU orphan designation number: EU/3/08/599   
Active ingredient: Exon 51 specific phosphorothioate oligonucleotide
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Prosensa Therapeutics B.V.
J. H. Oortweg 21, NL-2333 CH Leiden, Nederland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/03/2009 Centralised Orphan - Designation EMEA/OD/082/08 (2009)1525 of 27/02/2009
08/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/082/08/T/01 (2010)3713 of 04/06/2010
04/02/2014 Centralised Orphan - Change of address
15/04/2014 Centralised Orphan - Transfer of orphan designation EMEA/OD/082/08/T/02 (2014)2621 of 11/04/2014